Does robotic chordae shortening provide equivalent long-term valve competence compared to chordal transfer or neochordae in patients with anterior leaflet prolapse in degenerative mitral disease?
Robotic chordae shortening is a viable, tissue-preserving option for anterior leaflet prolapse in degenerative mitral disease, offering equivalent long-term valve competence and shorter hospital stays compared to alternative robotic techniques.
Robotic chordae shortening adds negligible operative time, shortens ICU and hospital stay, and delivers long-term valve competence equivalent to contemporary robotic repairs relying on chordal transfer or neochordae. Although new-onset atrial fibrillation was more frequent, other adverse events were rare. The robotic platform appears to overcome historical limitations of chordae shortening, restoring this tissue‑preserving option for anterior leaflet prolapse in degenerative mitral disease.
Wei et al. (Thu,) studied this question.